Clinical Trial · NCT06690970

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

Overview

To evaluate the potential usefulness of 68Ga/18F-PSMA/PSFA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various PSMA-related disease patients (prostate cancer, hepatic cancer, etc.).

Sponsor

Medical University of Vienna

Contacts

Haonan Yu, MD (CONTACT)

dreamadam@126.com

+8613821000597

ClinicalTrials.gov

NCT06690970